ArticleAntibiotics (Basel, Switzerland)2023

Could an Optimized Joint Pharmacokinetic/Pharmacodynamic Target Attainment of Continuous Infusion Piperacillin-Tazobactam Be a Valuable Innovative Approach for Maximizing the Effectiveness of Monotherapy Even in the Treatment of Critically Ill Patients with Documented Extended-Spectrum Beta-Lactamase-Producing

Milo Gatti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.